Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Julia Rawlings

Concepts (55)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Safety Management
2
2018
126
0.630
Why?
Patient Safety
2
2018
335
0.520
Why?
Pharmacy Service, Hospital
1
2018
83
0.510
Why?
Organizational Culture
1
2018
162
0.490
Why?
Remote Consultation
1
2022
63
0.180
Why?
Drug Overdose
1
2022
359
0.140
Why?
Pharmacy
1
2017
31
0.130
Why?
Pharmaceutical Services
1
2017
83
0.120
Why?
Benchmarking
1
2017
179
0.120
Why?
Opioid-Related Disorders
1
2022
568
0.110
Why?
Pharmacists
1
2017
256
0.110
Why?
Colchicine
1
2012
21
0.100
Why?
Gout Suppressants
1
2012
21
0.100
Why?
Hematologic Diseases
1
2012
66
0.090
Why?
Gout
1
2012
38
0.090
Why?
Chemical and Drug Induced Liver Injury
1
2012
143
0.080
Why?
Renal Insufficiency
1
2012
170
0.080
Why?
Delivery of Health Care
1
2017
948
0.080
Why?
Attitude of Health Personnel
1
2018
1178
0.080
Why?
Cross-Sectional Studies
2
2018
5653
0.080
Why?
Surveys and Questionnaires
2
2018
5948
0.070
Why?
Endrin
1
2022
13
0.050
Why?
Sumatriptan
1
1999
6
0.040
Why?
Health Maintenance Organizations
1
1999
105
0.040
Why?
Colorado
2
2022
4599
0.030
Why?
Migraine Disorders
1
1999
106
0.030
Why?
Pain
1
2022
779
0.030
Why?
Pharmacies
1
2017
42
0.030
Why?
Analgesics, Opioid
1
2022
1117
0.030
Why?
Counseling
1
2017
395
0.030
Why?
Practice Patterns, Physicians'
1
2022
1336
0.030
Why?
Humans
5
2022
141284
0.030
Why?
Cytochrome P-450 CYP3A Inhibitors
1
2012
18
0.020
Why?
Cytochrome P-450 CYP3A
1
2012
90
0.020
Why?
Insurance, Health, Reimbursement
1
2012
99
0.020
Why?
Drug Interactions
1
2012
404
0.020
Why?
Communication
1
2017
941
0.020
Why?
Enzyme Inhibitors
1
2012
835
0.020
Why?
United States
2
2022
15298
0.020
Why?
Prevalence
1
2012
2795
0.010
Why?
Case-Control Studies
1
2012
3577
0.010
Why?
Electronic Health Records
1
2012
1129
0.010
Why?
Cohort Studies
1
2012
5809
0.010
Why?
Efficiency
1
1999
101
0.010
Why?
Health Services
1
1999
116
0.010
Why?
Statistics, Nonparametric
1
1999
432
0.010
Why?
Cost of Illness
1
1999
311
0.010
Why?
Young Adult
1
2012
13727
0.010
Why?
Middle Aged
2
2012
34658
0.010
Why?
Patient Satisfaction
1
1999
695
0.010
Why?
Adult
2
2012
39319
0.010
Why?
Aged
1
2012
24836
0.010
Why?
Male
2
2012
70140
0.000
Why?
Female
2
2012
75814
0.000
Why?
Quality of Life
1
1999
3024
0.000
Why?
Rawlings's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)